Giant-Cell Tumor of Tendon Sheath clinical trials at UC Davis

1 research study open to eligible people

Vimseltinib for Tenosynovial Giant Cell Tumor
“Volunteer for research and contribute to discoveries that may improve health care for you, your family, and your community!”
open to eligible people ages 18 years and up
This is a multicenter Phase 3 clinical study, which aims to evaluate the effectiveness of an investigational drug called vimseltinib for the treatment of tenosynovial giant cell tumor (TGCT) in cases where surgical removal of the tumor is not an…
Sacramento, California and other locations

Last updated: February 2025

Vimseltinib for Tenosynovial Giant Cell Tumor